A mother's personal experience with opioid dependency during pregnancy became the catalyst for groundbreaking research. After witnessing newborns experience severe withdrawal symptoms immediately after birth, she pursued advanced academic study to explore innovative therapeutic interventions. Scientists are now examining the potential of probiotic supplements targeting the gut microbiome as a promising strategy to mitigate neonatal abstinence syndrome and improve outcomes for infants exposed to opioids in utero.

Summary auto-generated by AI from the original publisher's content. Editorial standards.